What if you'd held AXSM?
A $1,000 investment in Axsome Therapeutics, Inc. (AXSM) at the month-end close of 2015-11 would be worth $24,711 at the close of 2026-08 — +2371.1% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,705.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $728 | -27.2% |
| 2017 | $604 | -17.0% |
| 2018 | $304 | -49.6% |
| 2019 | $11,150 | +3565.2% |
| 2020 | $8,789 | -21.2% |
| 2021 | $4,076 | -53.6% |
| 2022 | $8,320 | +104.2% |
| 2023 | $8,586 | +3.2% |
| 2024 | $9,127 | +6.3% |
| 2025 | $19,702 | +115.9% |
| 2026 | $23,538 | +19.5% |
Best and worst month-end to buy
The best single month-end close to have bought AXSM was 2018-03 ($2.45): $1,000 then is $89,061 today. The worst was 2026-06 ($245): $1,000 then is $891.
FAQ
What would $1,000 in AXSM be worth today?
A $1,000 investment in Axsome Therapeutics, Inc. (AXSM) at the start of 2015 would be worth about $24,711 today, a total return of +2371.1%. Dividends are reinvested in these figures.
What were the best and worst years for AXSM?
Axsome Therapeutics, Inc. (AXSM)'s strongest calendar year since 2015 was 2019, a +3565.2% return — $1,000 held through that year became about $36,652 by year-end. Its weakest year was 2021, at -53.6%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in AXSM have grown?
Investing $100 at the end of every month since 2015-11 would have grown to about $219,071 on $13,000 invested.
Did AXSM beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,705. AXSM beat the S&P 500 by +567.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Axsome Therapeutics, Inc. (AXSM) historical total-return data from 2015-11 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.